Pre-surgery partial breast radiation for recurrent breast cancer
Part of Cancer, Skin clinical trials.
This trial tests a shorter course of radiation to just part of the breast before surgery for women who have had breast cancer return in the same breast. It's for those who have already had radiation to that breast and have a specific type of cancer (ER+, HER2-).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 51 years old or older.
- This is a breast cancer that has come back or is new in the same breast where you had cancer before.
- You have had radiation therapy to that breast in the past.
- Your cancer is estrogen receptor positive (ER+) and HER2 negative (HER2-).
- The tumor is 3 cm or smaller (or if it's DCIS, the affected area is 2.5 cm or smaller).
- You have no signs of cancer spread to lymph nodes or other parts of the body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial tests whether radiation to only part of the breast is safe and effective for women with early-stage breast cancer, without removing lymph nodes. The goal is to reduce side effects while keeping the cancer from coming back.
This trial tests a shorter course of radiation to only the part of the breast where cancer has come back. It's for women who had radiation years ago and now have a small new or recurrent tumor that can be removed by surgery.
This Phase 2 study tests whether giving targeted radiation again to the same breast can control a small, local breast cancer that came back after prior whole-breast radiation. It may help some patients avoid or delay further treatment for the breast while carefully checking safety.
This trial compares two slightly different doses of radiation (26 Gy vs 30 Gy) given in five quick sessions to just the part of the breast where cancer was removed. It is for people 50 and older with small, early-stage, non-aggressive breast cancers that are hormone positive and HER2 negative.
This trial tests giving a single, very targeted dose of radiation right after surgery for early-stage breast cancer. It is for women age 40+ with small, low-risk tumors (Luminal A or B) that have been fully removed and have not spread to lymph nodes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.